prostate header graphic
Prostate Problem Guide

The Use Of Medicine In BPH Treatment

There are a number of ways of treating BPH (benign prostatic hyperplasia or an enlarged prostate) of which medical treatments, or the use of drugs, is the commonest form of treatment following watchful waiting.

(Watchful waiting applies in cases where symptoms are mild or where the patient is not particularly troubled by his symptoms and involves simply checking on the patient once or twice a year to ensure that he is not developing complications as a result of his BPH. This can be a useful option for some patients as it avoids the risks associated with other forms of BPH treatment and, on occasions, the symptoms will actually lessen over time.)

One commonly used group of drugs in BPH treatment are alpha-blockers which were originally designed for the treatment of high blood pressure. Alpha-blockers act to relax the muscles of the prostate gland, as well as the neck of the bladder, and so reduce pressure on the urethra and improve the flow of urine.

Although alpha-blockers relieve BPH symptoms they do not reduce the size of the prostate and so the symptoms are likely to return if treatment is stopped. Alpha-blockers will usually produce a moderate reduction in symptoms and common side effects include dizziness, headaches, a stuffy nose and stomach and intestinal problems. These problems appear in about 12% to 15% of patients.

Another frequently prescribed group of drugs are 5-alpha reductase inhibitors. This particular group of drugs acts to lower the level of the main male hormone found in the prostate gland and thus marginally reduces the size of the enlarged prostate. It is however a very slow acting drug and patients will normally need to take the drug for 6 to 12 months before any effects are evident.

5-alpha reductase inhibitors usually produce less of a reduction in symptoms than alpha blockers but can be particular useful in cases where the prostate is considerably enlarged and patients are at risk of developing acute retention – an inability to urinate. Common side effects resulting from the reduction of the male hormone include erection problems, a decrease in sexual desire and a reduction in the amount of semen produced. These problems are seen in about 5% to 8% of patients.

In cases where the prostate is particularly enlarged and patients are finding that they are especially troubled by their symptoms, the doctor may recommend a combination of both alpha-blockers and 5-alpha reductase inhibitors.

In addition to prescription drugs patients may also wish to consider the use of herbal remedies. A number of such over-the-counter remedies are available but, at present, their effectiveness and safety have not been proved and none are approved for use by the Food and Drug Administration (FDA). In addition, the use of some of the herbal remedies available can lead to distortions in the results of diagnostic tests and also interfere with the actions of prescription drugs. As a result, you should consult your doctor before using any form of herbal remedy.

Further information on bph:

Patients with Benign Prostate Hyperplasia Evaluated for Infection after Holmium Laser Surgery - BPH News


BPH News

Patients with Benign Prostate Hyperplasia Evaluated for Infection after Holmium Laser Surgery
BPH News
Researchers at Gifu University Hospital in Japan examined the presence of postoperative bacteria in the urine (bacteriuria) and fever complications in patients with benign prostatic hyperplasia (BPH) who undergo holmium laser removal of tissue inside ...

Ameolioration of testosterone induced benign prostatic hyperplasia by Prunus species. - UroToday


Ameolioration of testosterone induced benign prostatic hyperplasia by Prunus species.
UroToday
The ethnomedicinal use of an African plant Prunus africana (Hook.f.) Kalkman (Pygeum) in treating men's problems made it a popular remedy all over the globe for the treatment of BPH and related disorders. However, rampant collections made from the wild ...

Benign Prostatic Hyperplasia Report 2016 - Pipeline Review of 20 Therapeutic Companies & Drug Profiles - Research ... - Business Wire (press release)


Benign Prostatic Hyperplasia Report 2016 - Pipeline Review of 20 Therapeutic Companies & Drug Profiles - Research ...
Business Wire (press release)
This report provides comprehensive information on the therapeutic development for Benign Prostatic Hyperplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...

and more »

Benign Prostatic Hyperplasia Pipeline Review, Market Share, Strategy, Size and Forecast 2016 – 2020 - Medgadget.com (blog)


Benign Prostatic Hyperplasia Pipeline Review, Market Share, Strategy, Size and Forecast 2016 – 2020
Medgadget.com (blog)
New Research “Benign Prostatic Hyperplasia Pipeline Review, H2 2015”, provides an overview of the Benign Prostatic Hyperplasia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Benign Prostatic ...

and more »